Introduction. Obesity is a risk factor for intensive care unit (ICU) admission in nonpregnant populations. Less is known about maternal obesity and ICU admission risk. The objective of this study was to estimate the association between maternal obesity and ICU admission among women who delivered via cesarean section or vaginal birth after cesarean section (VBAC). Material and methods. This is a retrospective cohort analysis of women who delivered via VBAC or cesarean section in the Maternal-Fetal Medicine Unit (MFMU) Cesarean Registry. We defined exposure as body mass index (BMI) at delivery stratified as non-obese (BMI 18.5-29.9 kg/m 2 ), class I or II obese (BMI 30-39.9 kg/m 2 ), morbidly obese (BMI 40-49.9 kg/m
Introduction
Super obesity, defined as body mass index (BMI) ≥50 kg/ m 2 or 225% above ideal body weight (1) , is becoming an increasingly frequent comorbidity of pregnancy in the USA. Currently, 2% of the US obstetrical population is
Key Message
Maternal super obesity is an independent risk factor for intensive care unit admission among women delivering by cesarean section or vaginal birth after cesarean section.
super obese (2, 3) , and this category is the fastest growing obesity group (4) . The contribution of obesity to increasing perinatal risk is substantial; pregnant women with class III obesity (BMI ≥ 40 kg/m 2 ) are at increased risk of peripartum hemorrhage (5) , wound complications (6) (7) (8) (9) (10) , and anesthetic complications (11, 12) . Maternal super obesity is associated with further increased risk of maternal morbidity, including increased risk of cesarean section (CS), hypertensive disorders of pregnancy and gestational diabetes (2, 3, 13) .
Intensive care unit (ICU) admission in the obstetric population is rare, ranging from 0.7 to 13.5 per 1000 deliveries (14) . Leading causes of maternal ICU admission are hypertensive disorders, hemorrhage, sepsis, and cardiac disease (14, 15) . In the nonpregnant population, obesity is an established risk factor for ICU admission and increased ICU morbidity and mortality (16) (17) (18) (19) (20) . Although previous studies have examined causes for obstetric ICU admission (21) , few studies have considered super obesity as a risk factor for maternal ICU admission and none in the USA, where the prevalence of super obesity in the obstetric population is the highest in the world (22, 23) .
A better understanding of the relation between maternal obesity and ICU admission is needed to help practitioners identify women in potential need of critical care in the intrapartum and immediate postpartum periods. The objective of this study was to assess if maternal super obesity is independently associated with ICU admission in a US high-risk obstetric population [i.e. those who delivered via vaginal birth after CS (VBAC) or CS]. We hypothesized that super obesity at time of delivery is a significant risk factor for maternal ICU admission among women delivering via CS or VBAC.
Material and methods
We performed a secondary analysis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit (MFMU) cesarean registry, a prospective study conducted from 1999 to 2002 in 19 academic centers. Briefly, at each center, study nurses collected demographic data, obstetrical history, and intrapartum and postpartum events for each participant (24) . This data set includes women who delivered via CS or VBAC. Because incidence of hemorrhage, infectious morbidity, and ICU admission increase with CS and VBAC compared with spontaneous vaginal delivery, this cohort is considered a high-risk cohort by the nature of its inclusion criteria (25) (26) (27) .
Our primary exposure was maternal BMI at time of delivery stratified as non-obese (BMI 18.5-29.9 kg/m 2 ), class I or II obese (BMI 30-39.9 kg/m 2 ), morbidly obese (BMI 40-49.9 kg/m 2 ) and super obese (BMI ≥ 50 kg/m 2 ).
We chose our BMI categories based on a review of the literature, which increasingly includes super obesity as a distinct risk factor for maternal morbidity (2, 23, 28) . We plotted the predicted probability of ICU admission by BMI at delivery to internally validate the use of our BMI categories. We excluded underweight women due to small numbers (n = 71). The BMI at time of delivery was calculated using the maternal height and weight measured by the healthcare team, which was abstracted from the participant's medical chart. Prepregnancy BMI was also abstracted from the medical chart and was largely based on self-reported weight. We defined the primary exposure as BMI at time of delivery, instead of prepregnancy BMI, for three reasons: (1) prepregnancy weight was not an objective, validated measure, (2) prepregnancy BMI data were missing in a large proportion (26%) of participants, and (3) BMI at delivery reflects prepregnancy BMI as well as gestational weight gain. We also performed a sensitivity analysis defining exposure categories based on prepregnancy BMI. The primary outcome was ICU admission during pregnancy, labor and delivery, or within 6 weeks postpartum. Research nurses abstracted charts and assessed the primary diagnosis leading to ICU admission.
To more thoroughly characterize the association between obesity and ICU admission, we also evaluated the primary reason for ICU admission, categorized as neurological (subdural hematoma, meningitis, neurology consultation, stroke, postoperative seizure); cardiopulmonary (mechanical ventilation, central line or radial artery line management, acute respiratory distress syndrome, cardiopulmonary arrest, uncontrolled hypertension, pulmonary edema); infection/wound complication (necrotizing fasciitis, sepsis, wound evisceration); coagulopathy; and other (not otherwise specified) by BMI strata. We also examined in-hospital maternal deaths by BMI strata. Trained research nurses reviewed the medical record and recorded the cause of death at the time of data collection for the original study.
We compared maternal demographics, clinical and delivery characteristics, and outcomes, across the four BMI strata using chi-squared test, chi-squared test for trend, or Fisher's exact test, as appropriate. Modified Poisson regression models with robust variance were used to estimate relative risk (RR) and 95% CI for the association between obesity and ICU admission. To identify potential confounders, we selected clinically relevant variables and those associated with both exposure and outcome in unadjusted analyses. We retained confounders in the final multivariable regression models if the covariable changed the relative risk estimate for the obesity-outcome association by at least 10%. We calculated the number of pregnant or postpartum women needing ICU admission from the frequency of ICU admission within each maternal BMI stratum with a binomial 95% CI for each point estimate.
We also explored the potential mediating effects of maternal medical comorbidities on the association between maternal obesity and ICU admission. We created two adjusted models adapted from methodology described elsewhere (29, 30) . Model 1 ("natural direct effect") is adjusted for confounders identified from the change-in-estimate approach (maternal race, preterm delivery < 37 weeks, hypertensive disorder of pregnancy, blood transfusion, anesthesia type, and mode of delivery) excluding maternal comorbidities; Model 2 ("natural indirect effect") further adjusts for medical comorbidities, including maternal heart disease and chronic disease (pregestational diabetes, pregestational hypertension requiring treatment, renal disease, asthma, seizure disorder, thyroid disease and connective tissue disorder). We calculated the proportion of the maternal obesity-ICU admission association mediated through medical comorbidity using the formula [RR
, where RR NDE and RR NIE are the corresponding odds ratios for direct effect of obesity and indirect effect mediated through maternal medical comorbidities (30) .
The University of North Carolina at Chapel Hill Institutional Review Board reviewed our study and deemed it exempt (IRB# 15-2099; date of exemption 21 August 2015) so no ethical approval was required.
Results
Our study cohort of 68 455 included 27 253 (40%) nonobese women, 31 521 (46%) women with class I or II obesity, 8055 (12%) with morbid obesity and 1626 (2%) who were super obese. Of the 68 455 women, 66 255 (97%) women with complete covariate and outcome data were included in our final multivariable model ( Figure 1 ). In this cohort, 82% (n = 56 050) of women underwent CD and 18% (n = 12 401) delivered via VBAC; 24% of all women were nulliparous (n = 16 035) ( Table 1) . With increasing severity of obesity, women were more likely to be Black, have an American Society of Anesthesiologists category 3 or 4, have chronic medical comorbidities, gestational diabetes, and/or hypertensive disorders of pregnancy.
Admission to ICU was infrequent (n = 447, 0.7%), and the frequency was highest among super obese women (n = 21, 1.3%) ( Table 2 ). In the entire cohort, median length of ICU stay was 1 day (range 1-87 days) and it did not differ by BMI. Most ICU admissions occurred immediately postpartum: 32% on day of delivery and 45% within 4 days after delivery. There was no association between day of ICU admission and BMI (p = 0.6). In this cohort, cardiopulmonary etiologies were the most common primary reason for ICU admission (n = 308, 0.5%) ( Table 2) . Although there was a higher frequency of ICU admission in the super obese population, the need for interventional critical services (i.e. mechanical ventilation, central or radial line placement) was similar between super obese and non-obese women.
We plotted the predicted probability of ICU admission by maternal BMI at delivery as a continuous variable (Figure 2 ). In Model 1 ("natural direct estimate"), super obese women had an almost two-fold increased risk of ICU admission compared with non-obese women (Table 3) . After further adjustment for medical comorbidities in Model 2 ("natural indirect estimate"), these associations were attenuated for women with super obesity. Maternal age, gestational diabetes, multiple gestation, labor, chorioamnionitis and previous CD did not change the adjusted RRs significantly and were not included in the final models. Among class I or II, 0% of obesity-related risk for ICU admission was attributable to medical comorbidities. Among women with morbid or super obesity, medical comorbidities mediated 44% and 58% of the obesity-related risk for ICU admission, respectively. In other words, 42-56% of the risk for ICU admission among super obese women is driven specifically by maternal obesity and not attributable to medical comorbidities.
In our cohort, we found that overall for every 153 deliveries (95% CI 139-168), there was one ICU admission. Among super obese women, 1 in 77 (95% CI 51-125) deliveries resulted in ICU admission, compared with 1 for every 144 (95% CI 126-168) deliveries among nonobese women, 1 in 179 (95% CI 155-209) for class I or II obese women, and 1 in 132 (95% CI 103-173) deliveries among morbidly obese women.
We performed a sensitivity analysis to assess the association between obesity, estimated from prepregnancy BMI, and ICU admission. Based on self-reported prepregnancy weight, 2.5% of women were underweight (n = 1718), 51% were non-obese (n = 35 126), 16% were class I or II obese (n = 10 818), 3% were morbidly obese (n = 2315), and 0.6% were super obese (n = 414). Notably, 26% had missing data for prepregnancy BMI (n = 18 058). With increasing prepregnancy obesity severity, women were less likely to change BMI categories over the duration of the pregnancy. For example, among women who were nonobese before pregnancy, 45% were classified as class I or II obese at time of delivery. In contrast, 96% of super obese women at delivery had a prepregnancy BMI ≥ 50 kg/m 2 . Women with prepregnancy super obesity had a five-fold increased risk of ICU admission compared with non-obese women (adjusted RRs 5.21, 95% CI 2.57-10.55) after adjustment for the same confounders as the multivariable Model 2 for BMI at delivery (n = 49 102 with complete data). We also examined the maternal deaths among women admitted to the ICU (n = 16); ten (62%) were non-obese, two (13%) were class I or II obese, three (19%) were morbidly obese and one (6%) was super obese. For the 16 women who died after ICU admission, hypertensive encephalopathy (n = 4) was the most common cause of death followed by intracranial hemorrhage (n = 3), multi-organ failure (n = 3), infection (n = 2), hemorrhage (n = 1), aortic dissection (n = 1), amniotic fluid embolism (n = 1), and hepatic failure (n = 1). There was no observed association between cause of maternal death and BMI category (p = 0.09).
Discussion
In this high-risk obstetric cohort, maternal super obesity at time of delivery was an independent risk factor for ICU admission. A sensitivity analysis within a sub-cohort of women with prepregnancy BMI data revealed similar findings. Maternal medical comorbidities partially mediate the risk of ICU admission associated with super obesity. However, the excess need for intensive care in obese patients is not entirely attributable to coexisting chronic disorders.
Admission to ICU in the USA obstetrical population is rare and little is understood about the risk factors for ICU admission. Non-US studies report that super obese women have a four-fold to seven-fold increased risk of ICU admission compared with non-super obese women (22, 23) , with no mention of the effect of maternal comorbidities on this association. Overall, our results are consistent with these studies -super obese women are at high risk of ICU admission in the peripartum period. Because of our large sample size, we are able provide a more comprehensive characterization of the association of super obesity, ICU admission, and the reasons for ICU admission across obesity categories.
Although our analysis shows a nearly two-fold relative risk of ICU admission for super obese women, this must be interpreted in the context of an absolute risk of 1.3% for super obese women compared with 0.7% for non-obese women (absolute risk difference 0.6%). In the USA, the rate of ICU admission has been estimated in the obstetric population as one admission for every 238-370 deliveries (14, 15) . In our cohort, women in the super obese strata required an ICU admission for every 77 deliveries. In our sensitivity analysis using prepregnancy BMI to define exposure, the number of deliveries for one ICU admission may be as low as eight among super obese women. However, this estimate should be interpreted with caution as prepregnancy BMI was based on self-reported weight, and 26% of our cohort had missing prepregnancy BMI.
The major strength of our study is the large number of women in this obstetric cohort at high risk of complications, which enabled us to evaluate rare exposures and outcomes such as super obesity and ICU admission. Our cohort includes approximately 2% of super obese women, which is consistent with other studies of maternal super obesity (2, 3, 13) . The MFMU Cesarean Registry is one of the largest validated obstetric databases, which includes prospectively collected information about women's pre-existing medical conditions, delivery complications, reason for ICU admission and maternal mortality. Our study provides nationwide data at 19 tertiary referral sites, all with ICU availability. Therefore, the results are based on high-quality data and are generalizable to a relatively wide range of obstetric populations in the USA delivering in tertiary-care centers.
Our study has several limitations. This data set reflects US obesity rates in the obstetrical population in 1999-2002, when 13 states had an overall obesity prevalence <18% (31). In 2015, no US states had an overall obesity prevalence < 18% (32). More contemporary cohorts, both from the USA and worldwide, may include more super obese women and may provide a more precise assessment of ICU needs in a high-risk obstetric population. Our cohort was collected from tertiary-care academic centers, which may have access to more specialized equipment, blood banks, extra staff; therefore information from this analysis may not be generalizable to all delivering institutions and may underestimate the need for ICU admission at smaller community hospitals or risk of death following ICU admission. Because the MFMU Cesarean Registry was designed to collect information on obstetrical outcomes, we do not have information characterizing illness severity such as Acute Physiology and Chronic Health Evaluation (APACHE) scores or details about the level of care pregnant and postpartum women needed in the ICU (i.e. vasopressors, frequency of laboratory blood samples, need for continuous positive airway pressure). We were also unable to investigate if obesity or super obesity increases morbidity in the ICU, Additionally, there may be unmeasured risk factors associated with obesity and ICU admission (such as obstructive sleep apnea, provider fear of adverse complication) as these detailed clinical variables were not collected. We did not have complete prepregnancy BMI data, which may have introduced significant selection bias. Women with missing prepregnancy BMI may be less likely to have regular care, which may lead to poorer health and an increased likelihood of ICU admission. Additionally, there may be additional unmeasured risk factors associated with obesity and ICU admission (for instance obstructive sleep apnea). Residual confounding by these factors may have weakened the associations that were observed. Due to the observational study design, the estimated association between maternal obesity and ICU admission should be interpreted with some level of uncertainty as there is the potential for residual bias. However, in light of other studies which have found an increased risk of ICU admission among women with super obesity, we believe that our study contributes to the growing body of literature that pregnant and postpartum women with super obesity have an increased risk of ICU admission (22, 23) , which may aid providers in delivery planning.
We also lacked sufficient power to evaluate maternal mortality differences in this population. Finally, this cohort only includes women who delivered via CS or VBAC and may not be generalizable to super obese women who have a normal vaginal delivery without a previous CS. However, nearly one-half of primigravidas with super obesity will deliver via CS; hence our results are applicable to the majority of super obese parturients (2) .
Conclusion
In the USA and globally, obesity among women of reproductive age is increasing (33) , pregnancy-related mortality is on the rise, and cardiovascular disease is now the most common cause of pregnancy-related death (34) . Critical illness requiring ICU admission among all pregnant and postpartum women is rare, including among super obese women; however, the consequences of delayed diagnosis and need for transfer to higher level of care may be dire (35) . Given current obesity trends, the need for facilities with sufficient expertise in obstetrics and critical care and capability of caring for high-risk pregnant women is likely to increase in the near future (36) . From a systems-based approach, we provide evidence for supporting increases in ICU beds in tertiary referral centers providing care for super obese parturients. On the patient care level, we suggest that maternal super obesity should be considered when developing a delivery care plan, including decisions on delivery mode, timing, and location. Clinicians may consider implementation of obesity safety pathways that include transfer of care from community/smaller hospitals to larger tertiary centers with ICU capability when delivering super obese women. Based on our data from the MFMU Cesarean Registry, if a community hospital were to adopt a policy of transferring super obese women to a referral center for prenatal or delivery care a small minority of women would require transfer and roughly 77 super obese women would require transfer to a referral center to avert one ICU admission at a non-tertiary health center.
